期刊文献+

缩泉丸对肾虚多尿大鼠肾素-血管紧张素-醛固酮系统的影响 被引量:26

Experimental Study of Suoquan Capsule on Renin-Angiotensin-Aldosterone System in Rats with Diuresis and Deficiency of Kidney
原文传递
导出
摘要 目的:通过研究缩泉丸对肾素-血管紧张素-醛固酮系统(RAAS)的调节作用,阐明其补肾缩尿的机制。方法:采用腺嘌呤造成肾虚多尿大鼠模型,利用酶联免疫分析法分别检测正常对照组、模型对照组、缩泉丸组、金锁固精丸组血中血管紧张素转化酶(ACE)、肾素(PRA)、血管紧张素Ⅱ(AngⅡ)、醛固酮(ALD)的含量。结果:与模型对照组比较,缩泉丸可显著提高肾虚多尿大鼠血中ACE,PRA,AngⅡ,ALD含量。结论:缩泉丸可通过调节RAAS的功能发挥调节人体水液代谢的作用,本试验研究结果从内分泌系统调节的角度阐明了缩泉丸补肾缩尿的作用机制。 Objective:To expound the mechanism of nourishing kidney and reducing urine by investigating the regulative action for renin-angiotensin-aldosterone system(RAAS) by Suoquan Capsule.Method:The rat model of kidney deficiency and diuresis was established by adenine.The levels of ACE,PRA,AngⅡ and ALD in blood were determined for model group,Suoquan Capsule group,Jinsuo Gujin Wan group and control group with ELISA technology.Result:Compared with model group,Suoquan Capsule could remarkedly increase the levels of ACE,PRA,AngⅡ and ALD in blood of the rats with kidney deficiency and diuresis.Conclusion:Suoquan Capsule can regulate water metabolism by coordinating the function of RAAS.The mechanism of nourishing the kidney and reducing urine by Souquan Capsule appears to be related with endocrinium system.
出处 《中国实验方剂学杂志》 CAS 北大核心 2010年第11期108-110,共3页 Chinese Journal of Experimental Traditional Medical Formulae
基金 国家自然科学基金项目(30873425)
关键词 缩泉丸 肾虚多尿 肾素-血管紧张素-醛固酮系统 Suoquan Capsule deficiency of the kidney with diuresis renin-angiotensin-aldosterone system
  • 相关文献

参考文献4

二级参考文献86

  • 1周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1401
  • 2吴瑜璇,祝宇.特发性醛固酮增多症手术是否必要?[J].中华内分泌代谢杂志,2005,21(5):475-476. 被引量:8
  • 3Sironi L,Calvio AM,Arnaboldi L,et al.Effect of valssrtan on angiotensin Ⅱ-induced plasminogen activator inhibitor-1 biosynthesis in arterial smooth muscle cells [J].Hypertension,2001,37(3):961~966
  • 4Labinjoh C,Newby DE,Dawson P,et al.Fibrinolytic actions of intraarterial angiotensin Ⅱ and bradykinin in vivo in man[J].Cardiovasc Res,2000,47(4):707~714
  • 5Nishimura H,Tsuji H,Masuda H,Nakagawa K,et al.Angiotensin Ⅱ increases plasminogen activator inhibitor-1 and tissue factor mRNA expression without changing that of tissue type plasminogen activator or tissue factor pathway inhibitor in cultured rat aortic endothelial cells.Thromb Haemsst,1997,77(6):1189~1195
  • 6Nagata K,Ishibashi T,Sakamoto T,et al.Effects of blockade of the renin-angiotensin system on tissue factor and plasminogen activator inhibitor-1 synthesis in human cultured monocytes [J].J Hypertens,2001,19(4):775~783
  • 7Jagroop IA,Mikhailidis DP.Angiotensin Ⅱ can induce and potentiate shape change in human platelets:effect of losartan[J].J Hum Hypertens,2000,14(9):581~585
  • 8Daugherty A,Rateri DL,Lu H,et al.Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor [J].Circulation,2004,110(2):3849~3857
  • 9Wassmann S,Czech T,Eickels MV,et al.Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin Ⅱ type 1A receptor double-knockout mice[J].Circulation,2004,110(19):3062~3067
  • 10Pueyo ME,Gonzalez W,Nicoletti A,et al.Angiotensin Ⅱ stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-k B activation induced by intracellular oxidative stress [J].Arterioscler.Thromb Vase Biol,2000,20(3):645~651

共引文献20

同被引文献265

引证文献26

二级引证文献175

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部